|
Summary Toggle
Sep 22, 2021 at 4:30 PM EDT
|
|
Webinar Featuring Expert Overview from Key Opinion Leaders
|
|
|
Summary Toggle
Sep 22, 2021
|
|
3rd Annual RAS Targeted Drug Development Summit 11:30 a.m. ET
Phase 1/2 Trial of Rigosertib & Nivolumab in KRAS-Mutated NSCLC in 2nd+ Line presented by Rajwanth Veluswamy, MD MSCR, Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai, NYC
|
|
|
Summary Toggle
Sep 13 - 15, 2021
|
|
H.C. Wainwright 23rd Annual Global Investment Conference
|
|
|
Summary Toggle
Aug 12, 2021 at 4:30 PM EDT
|
|
Q2 2021 Onconova Therapeutics, Inc. Corporate Update and Financial Results Conference Call
|
|
|
Summary Toggle
Jul 30, 2021 at 11:00 AM EDT
|
|
2021 Annual Meeting of Stockholders (Virtual)
|
|
|
Summary Toggle
Jun 10 - 18, 2021
|
|
Presentation at 2021 BIO Digital
|
|
|
Summary Toggle
May 17, 2021 at 4:30 PM EDT
|
|
Q1 2021 Onconova Therapeutics, Inc. Corporate Update and Financial Results Conference Call
|
|
|
Summary Toggle
Apr 30, 2021 at 4:30 PM EDT
|
|
|
Summary Toggle
Apr 1, 2021 at 11:50 AM EDT
|
|
Spring 2021 Oncology Investor Conference
|
|
|
Summary Toggle
Mar 17 - 18, 2021
|
|
The Maxim Group Emerging Growth Virtual Conference
|
|
|
Summary Toggle
Mar 15 - 17, 2021
|
|
The Virtual 33rd Annual Roth Conference
|
|
|
Summary Toggle
Mar 11, 2021 at 4:30 PM EST
|
|
Q4 2020 Onconova Therapeutics, Inc. Earnings Conference Call
|
|
|
Summary Toggle
Mar 9 - 10, 2021
|
|
The H.C. Wainwright Global Life Sciences Virtual Conference
|
|
|
Summary Toggle
Feb 16 - 18, 2021
|
|
BIO CEO & Investor Digital Conference
|
|
|
Summary Toggle
Jan 20, 2021 at 4:30 PM EST
|
|
|
Summary Toggle
Jan 11 - 15, 2021
|
|
Biotech Showcase virtual event
|
|
|
Summary Toggle
Nov 12, 2020 at 4:30 PM EST
|
|
Q3 2020 Onconova Therapeutics, Inc. Earnings Conference Call
|
|
|
Summary Toggle
Oct 13 - 15, 2020
|
|
2020 BIO Investor Forum Digital Event
|
|
|
Summary Toggle
Sep 16, 2020
|
|
2nd RAS-Targeted Drug Development Summit
|
|
|
Summary Toggle
Sep 14, 2020 at 1:30 PM EDT
|
|
HCWCO 22nd Annual Global Investor Conference – NYC
|
|
